Home » Stocks » Benitec Biopharma

Benitec Biopharma Inc. (BNTC)

Stock Price: $8.31 USD 0.00 (0.00%)
Updated Aug 13, 2020 4:00 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 13.35M
Revenue (ttm) 11.55M
Net Income (ttm) 2.93M
Shares Out 1.07M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $8.31
Previous Close $8.31
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 8.10 - 8.75
Day's Volume 0
52-Week Range 4.14 - 19.80

More Stats

Market Cap 13.35M
Enterprise Value -2.80M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 1.07M
Float 752,368
EPS (basic) n/a
EPS (diluted) -0.82
FCF / Share 2.94
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 28.32%
Payout Ratio n/a
Shares Short 3,629
Short Ratio 0.50
Short % of Float 0.70%
Beta 1.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 3.53
PS Ratio 1.16
PB Ratio 162.35
Revenue 11.55M
Operating Income 1.94M
Net Income 2.93M
Free Cash Flow 3.78M
Net Cash 16.15M
Net Cash / Share 10.05
Gross Margin 100.00%
Operating Margin 16.76%
Profit Margin 25.30%
FCF Margin 32.72%
ROA -21.76%
ROE -38.83%
ROIC n/a
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$14.00*
Low
14.0
Current: $8.31
High
14.0
Target: 14.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions AUD.

Financial Overview

Year201920182017201620152014
Revenue16.160.380.330.461.080.60
Revenue Growth4174.87%13.51%-28.23%-57.08%80.77%-
Gross Profit16.160.380.330.461.080.60
Operating Income2.71-15.88-16.18-27.95-14.40-7.38
Net Income4.09-11.64-5.69-24.78-11.51-7.04
Shares Outstanding25.7020.5114.6511.5911.59-
Earnings Per Share3.18-11.06-6.48-34.82-19.92-15.56
Operating Cash Flow5.86-9.79-8.30-20.21-9.69-9.27
Capital Expenditures-0.57-0.08-0.17-0.34-0.51-0.03
Free Cash Flow5.29-9.88-8.48-20.55-10.20-9.30
Cash & Equivalents22.5916.2217.4818.2621.7931.36
Net Cash / Debt22.5916.2217.4818.2621.7931.36
Assets27.4321.3422.6719.8925.5234.50
Liabilities3.772.601.161.051.640.96
Book Value23.6618.7421.5118.8423.8833.54
Numbers in millions AUD, except per-share numbers.

Company Profile

Company Details

Full Name Benitec Biopharma Inc.
Country United States
CEO Jerel A. Banks

Stock Information

Ticker Symbol BNTC
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: BNTC

Description

Benitec Biopharma, Inc., a development-stage biotechnology company, focuses on the advancement of novel genetic medicines. Its proprietary silence and replace approach combines DNA-directed RNA interference with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions, including oculopharyngeal muscular dystrophy (OPMD), and chronic hepatitis B. The company was founded in 1995 and is based in Hayward, California.